Nationwide
[18F]PT2385 PET/CT in Patients With Renal Cell Carcinoma
Orhan Kemal Oz
Procedure·Ph 1·~6yr·1 site in TX
Enrolling now
Check if I qualifyShowing 1–24 of 55 trials
Orhan Kemal Oz
James Brugarolas
Xynomic Pharmaceuticals, Inc.
UNC Lineberger Comprehensive Cancer Center
University of California, San Francisco
City of Hope Medical Center
Merck Sharp & Dohme LLC
Case Comprehensive Cancer Center
Beth Israel Deaconess Medical Center
HiberCell, Inc.
A2 Biotherapeutics Inc.
john eisenbrey
Neonc Technologies, Inc.
M.D. Anderson Cancer Center
Shanghai Henlius Biotech
Memorial Sloan Kettering Cancer Center
University of Texas Southwestern Medical Center
Abramson Cancer Center at Penn Medicine
M.D. Anderson Cancer Center